ANTX
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
133 days until earnings call
PHRRF
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

ANTX vs PHRRF

Header iconANTX vs PHRRF Comparison
Open Charts ANTX vs PHRRFBanner chart's image
AN2 Therapeutics
Price$1.01
Change-$0.00 (-0.00%)
Volume$1.32M
CapitalizationN/A
PharmaTher Holdings
Price$0.16
Change-$0.00 (-0.00%)
Volume$207.71K
CapitalizationN/A
ANTX vs PHRRF Comparison Chart
Loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ANTX vs. PHRRF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Hold and PHRRF is a StrongSell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ANTX: $1.00 vs. PHRRF: $0.16)
Brand notoriety: ANTX and PHRRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 531% vs. PHRRF: 64%
Market capitalization -- ANTX: $29.84M vs. PHRRF: $14.59M
ANTX [@Biotechnology] is valued at $29.84M. PHRRF’s [@Biotechnology] market capitalization is $14.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 1 FA rating(s) are green whilePHRRF’s FA Score has 0 green FA rating(s).

  • ANTX’s FA Score: 1 green, 4 red.
  • PHRRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ANTX is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 5 TA indicator(s) are bullish while PHRRF’s TA Score has 4 bullish TA indicator(s).

  • ANTX’s TA Score: 5 bullish, 4 bearish.
  • PHRRF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANTX is a better buy in the short-term than PHRRF.

Price Growth

ANTX (@Biotechnology) experienced а -9.09% price change this week, while PHRRF (@Biotechnology) price change was -4.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +6.16%.

Reported Earning Dates

ANTX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANTX($29.8M) has a higher market cap than PHRRF($14.2M). PHRRF YTD gains are higher at: -32.625 vs. ANTX (-95.120).
ANTXPHRRFANTX / PHRRF
Capitalization29.8M14.2M210%
EBITDA-71.17MN/A-
Gain YTD-95.120-32.625292%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash105MN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ANTXPHRRF
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXY51.120.83
+1.65%
Occidental Petroleum Corp
AXS84.480.67
+0.80%
Axis Capital Holders Limited
GAMB10.30-0.02
-0.19%
Gambling.com Group Limited
CAL31.76-0.09
-0.28%
Caleres
XPL0.56-0.03
-5.47%
Solitario Resources Corp

ANTX and

Correlation & Price change

A.I.dvisor tells us that ANTX and NKTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and NKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
-5.66%
NKTX - ANTX
26%
Poorly correlated
-4.59%
CSLLY - ANTX
26%
Poorly correlated
+0.01%
RANI - ANTX
25%
Poorly correlated
-3.50%
CERO - ANTX
24%
Poorly correlated
-20.71%
SCPX - ANTX
24%
Poorly correlated
-7.48%
More

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
+4.32%
HOTH - PHRRF
24%
Poorly correlated
-5.90%
RLYB - PHRRF
20%
Poorly correlated
-2.25%
INNMF - PHRRF
20%
Poorly correlated
-14.29%
ANTX - PHRRF
20%
Poorly correlated
-5.66%
KMSTF - PHRRF
13%
Poorly correlated
N/A
More